Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Marcinak

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|April 24, 2024
Phase 1 study of safety and tolerability of an oral contraceptive containing low-dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal womenDee-Dee Shiller, Betty B Yao, Mong-Jen Chen, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2019
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver diseaseMelissa Palmer, Arie Regev, Keith Lindor, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2025
Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus InterferonHashem B El-Serag, Hao Duong, Michelle Luster, et al.
The Pediatric Infectious Disease Journal|September 29, 2006
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapyMark J Abzug, Stephen I Pelton, Lin-Ye Song, et al.
Alimentary Pharmacology & Therapeutics|February 15, 2019
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitisArie Regev, Melissa Palmer, Mark I Avigan, et al.
Drug Safety|November 3, 2020
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic SteatohepatitisWilliam R Treem, Melissa Palmer, Isabelle Lonjon-Domanec, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Viral Hepatitis|April 24, 2024
Phase 1 study of safety and tolerability of an oral contraceptive containing low-dose ethinyl oestradiol combined with glecaprevir/pibrentasvir treatment in healthy premenopausal womenDee-Dee Shiller, Betty B Yao, Mong-Jen Chen, et al.
Alimentary Pharmacology & Therapeutics|November 26, 2019
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver diseaseMelissa Palmer, Arie Regev, Keith Lindor, et al.
Alimentary Pharmacology & Therapeutics|February 8, 2025
Risk of Hepatocellular Cancer in U.S. Patients With Compensated Cirrhosis Treated With Direct-Acting Antivirals Versus InterferonHashem B El-Serag, Hao Duong, Michelle Luster, et al.
The Pediatric Infectious Disease Journal|September 29, 2006
Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapyMark J Abzug, Stephen I Pelton, Lin-Ye Song, et al.
Alimentary Pharmacology & Therapeutics|February 15, 2019
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitisArie Regev, Melissa Palmer, Mark I Avigan, et al.
Drug Safety|November 3, 2020
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic SteatohepatitisWilliam R Treem, Melissa Palmer, Isabelle Lonjon-Domanec, et al.
Pageof 2